Recruiting

Yoga Therapy

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT05681026

Conditions

Hematopoietic Stem Cell Transplantation

Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Yoga Sessions

Questionnaries

Interviews

Study Details

Brief summary:

To develop and measure the effects of a culturally sensitive yoga program for inpatients

Conditions

Hematopoietic Stem Cell Transplantation

Cancer

Study ID

NCT05681026

Start date

Aug 28, 2023

Status verified date

Feb, 2026

Completion date

Jan 31, 2028

Anticipated

Primary completion date

Jan 31, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Cancer patients scheduled to undergo an autologous or allogeneic HSCT at MD Anderson, HCG, or MNH;
2. Age 18 or older;
3. English, Hindi, or Swahili speaking;
4. Able to sign a written informed consent and be willing to follow protocol requirements.

Exclusion Criteria:

  • Extreme mobility issues that preclude participating in the YT;
  • Major thought disorders such as schizophrenia or uncontrolled bipolar disorder;
  • HCT comorbidity score of 3 or higher, excluding cancer diagnoses

Study Design

Enrollment

60 participants

Anticipated

Intervention Model

Single group

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Yoga Sessions

Participants will take part in Yoga of gentle movements, breathing exercises, relaxation techniques, and meditation all tailored to the participant's needs.

Interventions

Yoga Sessions

Participants will have up to 12 sessions, 3 sessions per week starting two weeks before the transplant and throughout the first 30 days of your hospitalization.

Questionnaries

Participants will complete 4 questionnaires about any symptoms you may be having, any anxiety and/or depression you may be having, your quality of life, and your expectations about your treatment.

Interviews

Participants will have an exit interview last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom, FaceTime, or other approved video call methods.). The interview will be audio and video recorded and transcribed (typed).

Primary outcome measure

  • Patient Health Questionnaire-8 (PHQ-8) [ Time Frame: through study completion; an average of 1 year ]

Central Contacts and Locations

Central contacts

Lorenzo Cohen, PHD

(713) 745-4260lcohen@mdanderson.org

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Lorenzo Cohen, PHD

713-745-4260lcohen@mdanderson.org

Principal Investigator:

Lorenzo Cohen, PHD

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Feb 27, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-02-27.